NMSC e PDT

0
1698

Dermakos;2,38-50

  1. Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br. J. Dermatol 2012;166:1069-1080.
  2. Roewert-Huber J, Lange-Asschenfeldt B, Stockfleth E, Kerl H. Epidemiology and aetiology of basal cell carcinoma. Br. J. Dermatol 2007;157:47-51.
  3. Gaulin C, Sebaratnam dF, Fernández-Peñas P. Quality of life in non-melanoma skin cancer. Australas J dermatol. 2015;56:70-6.
  4. Madan V, Lear JT, Szeimies RM. Non-melanoma skin cancer. Lancet 2010;375:673-85.
  5. Karagas MR, Nelson HH, Zens MS, Linet M, Stukel TA, Spencer S et al. Squamous cell and basal cell carcinoma of the skin in relation to radiation therapy and potential modification of risk by sun exposure. Epidemiology 2007;18:776-84.
  6. Guenther lC, Barber K, Searles Ge, lynde CW, Janiszewski P, Ashkenas J. Canadian non-melanoma Skin Cancer Guidelines Committee. Non-melanoma Skin Cancer in Canada. Chapter 1: introduction to the Guidelines. J Cutan med Surg 2015;19:205-15.
  7. Malvehy J, Pellacani G. Dermoscopy, confocal microscopy and other non-invasive tools for the diagnosis of non-melanoma skin cancers and other skin conditions. Acta Derm Venereol. 2017 Jul 5.
  8. Guida S, Longo C, Casari A, Ciardo S, Manfredini M, Reggiani C, Pellacani G, Farnetani F. Update on the use of confocal microscopy in melanoma and non-melanoma skin cancer. G Ital Dermatol Venereol. 2015 Oct;150(5):547-63.
  9. Malvehy J. A new vision of actinic keratosis beyond visible clinical lesions. J Eur Acad Dermatol Venereol. 2015 Jan;29 suppl 1:3-8.
  10. Di Stefani A., Del Regno L., Piccerillo A., Peris K. Practical indications for the management of non-melanoma skin cancer patients. Giornale italiano di dermatologia e Venereologia. 2017 June;152(3):286-94.
  11. Kuijpers DI, Thissen MR, Berretty PJ, Ideler FH, Nelemans PJ, Neumann MH. Surgical excision versus curettage plus cryosurgery in the treatment of basal cell carcinoma. Dermatol Surg 2007;33:579-87.
  12. Barlow JO, Zalla MJ, Kyle A, Di Caudo DJ, Lim KK, Yiannias JA. Treatment of basal cell carcinoma with curettage alone. J Am Acad Dermatol 2006;54:1039-45.
  13. Trakatelli M, Morton C, Nagore E, Ulrich C, Del Marmol V, Peris K et al. Update of the European guidelines for basal cell carcinoma management. Eur J Dermatol 2014;24:312-29.
  14. Cappuggi P. Terapia fotodinamica nella pratica clinica. SEE Firenze 2005.
  15. Monti M., Motta S. manuale di terapia fotodinamica in dermatologia. Lampi di stampa 2005.
  16. Calzavara-Pinton PG, Szeimies RM, Ortel B. Photodynamic therapy and fluorescence diagnosis in dermatology. Elsevier, Amsterdam, 2001.
  17. Henderson BW et al. Photosensitizers in PDT. Semin.Oncol. 1994;21:4-10.
  18. Gomer CJ. et al. Molecular, cellular and tissue response following PDT. Laser Surg Med. 1988;8:450-463.
  19. Calzavara-Pinton P, Szeimies RM, Ortl B, Zane C. Photodynamic therapy with systemic administration of photosensitizers in dermatology. J Photochem Photobiol. B. 1996;36:225-231.
  20. Roberts DJH, et al. Tumor vascular shotdown following photodynamic therapy based on polyhaematoporphirin. Int J Oncol 1994;5:763-768.
  21. Luo Y et al. Rapid initiation of apoptosis by PDT. Photochem Photobiol 1996;63:528-534.
  22. Korbelik M. Induction of tumor immunity by PDT. J Clin Laser Med Surg 1996;14:329-334.
  23. Fischer AM et al. Clinical and pre-clinical PDT. Laser Surg Med 1995;17:2-31.
  24. Wilson C, Patterson MS, et al. Photomigration in tissue, Plenum, New York, 1990, p.25.
  25. Griffin LL, Lear JT. Photodynamic therapy and non-melanoma skin cancer. Cancers (Basel). 2016 Oct 22;8(10).
  26. Cohen DK, Lee PK. Photodynamic therapy for non-melanoma skin cancers. Cancers (Basel). 2016 Oct 4;8(10)
  27. Diffey BL, Langtry JAA. Skin cancer incidence and the ageing population. Br J Dermatol. 2005;153:679-80.
  28. Gailani MR, Leffell DJ, Ziegler A, Gross EG, Brash DE, Bale AE. Relationship between sunlight exposure and a key genetic alteration in basal cell carcinoma. J Natl Cancer Inst. 1996;88:349-54.
  29. Sekulic A, Migden MR, Oro AE, Dirix L, Lewis KD, Hainsworth JD et al. Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N Engl J Med. 2012;366:2171-9.
  30. Christenson LJ, Borrowman TA, Vachon CM, Tollefson MM, Otley CC, Weaver AL, Roenigk RK. Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years. JAMA. 2005 Aug 10;294(6):681-90.
  31. Ziegler A, Leffell DJ, Kunala S, Sharma HW, Gailani M, Simon JA, Halperin AJ, Baden HP, Shapiro PE, Bale AE et al. Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc Natl Acad Sci USA. 1993 May 1;90(9):4216-20.
  32. Marzuka AG, Book SE. Basal Cell Carcinoma: pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management. Yale J Biol Med. 2015 Jun 1;88(2):167-179.
  33. Menzies SW, Westerhoff K, Rabinovitz H et al. Surface microscopy of pigmented basal cell carcinoma. Arch Dermatol 2000;136:1012-1016.
  34. Altamura D, Menzies SW, Argenziano G et al. Dermatoscopy of basal cell carcinoma: morphologic variability of global and local features and accuracy of diagnosis. J Am Acad Dermatol 2010; 62:67-75.
  35. Giacomel J, Zalaudek I. Dermoscopy of superficial basal cell carcinoma. Dermatol Surg 2005;31:1710-3.
  36. Farnetani F, Scope A, Braun RP, Gonzalez S, Guitera P, Malvehy J, Manfredini M, Marghoob AA, Moscarella E, Oliviero M, Puig S, Rabinovitz HS, Stanganelli I, Longo C, Malagoli C, Vinceti M, Pellacani G. Skin Cancer diagnosis with reflectance confocal microscopy: reproducibility of feature recognition and accuracy of diagnosis. JAMA Dermatol. 2015 Oct;151(10):1075-80.
  37. Totonchy M, Leffell D. Emerging concepts and recent advances in basal cell carcinoma. F1000Res. Dec 2017.
  38. Fiechter S, Skaria A, Nievergelt H, Anex R, Borradori L, Parmentier L. Facial basal cell carcinomas recurring after photodynamic therapy: a retrospective analysis of histological subtypes. Dermatology 2012;224:346-351
  39. Cohen DK, Lee PK. Photodynamic Therapy for Non-Melanoma Skin Cancer Cancer 2016,8,90
  40. Vinciullo C, Elliott T, Francis D, Gebauer K, Spelman L, Nguyen R, Weightman W, Sheridan A, Reid C, Czarnecki D et al. Photodynamic therapy with topical methyl aminolaevulinate for “difficult-to-treat” basal cell carcinoma. Br. J. Dermatol. 2005;152:765-772
  41. Szeimies RM, Ibbotson S, Murrell DF, Rubel D, Frambach Y, de Berker D, Dummer R, Kerrouche N, Villemagne H. A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20 mm), with a 12-month follow-up. J. Eur. Acad. Dermatol. Venereol. 2008;22:1302-1311.
  42. Basset-Seguin N, Ibbotson SH, Emtestam L, Tarstedt M, Morton C, Maroti M, Calzavara-Pinton P, Varma S, Roelandts R, Wolf P. Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial. Euro. J. Dermatol. 2008; 18:547-553.
  43. Arits, A.H.M.M, Mosterd, K, Essers, B.A.B, Spoorenberg, E, Sommer, A, de Rooij, M.J.M, van Pelt, H.P, Quaedvlieg, P.J, Krekels, G.A, van Neer, P.A, et al. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial. Lancet Oncol. 2013;14:647-654.
  44. Foley P, Freeman M, Menter A, Siller G, El-Azhary RA, Gebauer K, Lowe NJ, Jarratt NT, Murrell DF, Rich P et al. Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: Results of two randomized studies. Inter. J. Dermatol. 2009;48:1236-1245.
  45. Tope WD, Menter A, El-Azhary RA, Lowe NJ. Comparison of topical methylaminolevulinate photodynamic therapy versus placebo photodynamic therapy in nodular basal cell carcinoma. J. Am. Acad. Dermatol. 2004;50:123.
  46. Rhodes, L.E, de Rie, M.A, Leifsdottir, R, Yu, R.C, Bachmann, I, Goulden, V, Wong, G.A, Richard, M.A, Anstey, A, Wolf, P. Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs. surgery for nodular basal cell carcinoma. Arch. Dermatol. 2007;143:1131-1136.
  47. Fantini F, Greco ADGC, Del Giovane C, Cesinaro AM, Venturini M, Zane C, Surrenti T, Peris K, Calzavara-Pinton PG. Photodynamic therapy for basal cell carcinoma: clinical and pathological determinants of response. J. Eur. Acad. Dermatol. Venereol. 2011;25:896-901.
  48. Neagu TP, Ţigliş M, Botezatu D, Enache V, Cobilinschi CO, Vâlcea-Precup MS, GrinŢescu IM. Clinical, histological and therapeutic features of Bowen’s disease. Rom J Morphol Embryol. 2017;58(1):33-40.
  49. Zalaudek I, Argenziano G, Leinweber B, Citarella L, Hofmann-Wellenhof R, Malvehy J, Puig S, Pizzichetta MA, Thomas L, Soyer HP, Kerl H. Dermoscopy of Bowen’s disease. Br J Dermatol, 2004;150(6):1112-1116.
  50. Hernández-Gil J, Fernández-Pugnaire MA, Serrano-Falcón C, Serrano-Ortega S. Clinical and dermoscopic features of pigmented Bowen disease. Actas Dermosifiliogr, 2008;99(5):419-420.
  51. Payapvipapong K, Tanaka M. Dermoscopic classification of Bowen’s disease. Australas J Dermatol, 2015;56(1):32-35.
  52. Morton C, Horn M, Leman J, Tack B, Bedane C, Tjioe M, Ibbotson S, Khemis A, Wolf P. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or fluorouracil for treatment of squamous cell carcinoma in situ. Results of a multicenter randomized trial. Arch. Dermatol. 2006;142:729-735.
  53. Lopez N, Meyer-Gonzalez T, Herrera-Acosta E, Bosch R, Castillo R, Herrera E. Photodynamic therapy in the treatment of extensive Bowen’s disease. J. Dermatol. Treat. 2012;23:428-430.
  54. Truchuelo M, Fernandez-Guarino M, Fleta B, Alcantara J, Jaen P. Effectiveness of photodynamic therapy in Bowen’s disease: an observational and descriptive study in 51 lesions. J. Eur. Acad. Dermatol. Venereol. 2012;26:868-874.
  55. Griffin LL, Lear JT. Photodynamic therapy and non-melanoma skin cancer. Cancers (Basel). 2016 Oct 22;8(10).